60 Degrees Pharmaceuticals Announces 2024 Annual Results
Provided By GlobeNewswire
Last update: Mar 28, 2025
WASHINGTON, March 28, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, reported today their financial results for the 2024 fiscal year, ended December 31, 2024.
Read more at globenewswire.comNASDAQ:SXTPW (7/15/2025, 8:24:43 PM)
0.0583
+0.02 (+66.57%)
1.75
-0.41 (-19.17%)
Find more stocks in the Stock Screener
